About: http://data.cimple.eu/news-article/26deef238c102b44c560b71378e0125abb22fa5bddf6b85f4ad770de

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/26deef238c102b44c560b71378e0125abb22fa5bddf6b85f4ad770de Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Swiss pharmaceuticals giant Roche said Friday it had received the green light in the United States for emergency use of a diagnostic test differentiating between coronavirus and influenza. Amid fears the flu season will place additional burdens on health system, authorities are keen to see tests which can distinguish coronavirus from other seasonal illnesses, notably flu. Roche said its cobas SARS-CoV-2 & Influenza A/B test had won Emergency Use Authorization approval from the US Food and Drug Administration (FDA). The firm added the test would also be available for use in countries where the European CE certification mark applies. "With the approaching flu season, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be differentiated by symptoms alone," said Thomas Schinecker, CEO of Roche Diagnostics. "Now, with a single test, healthcare professionals can confidently provide the right diagnosis and most effective treatment plan for their patients." The test uses nasal or nasopharyngeal swab samples taken from people suspected of having a respiratory infection and will be used on fully automated cobas 6800 and 8800 diagnostic machines which are common in hospitals and which can carry out out large-volume testing. Roche said for this test the machines can provide up to 96 results in roughly three hours to offer "the fastest time to results with the highest throughput" for testing of SARS-CoV-2 (coronavirus) and Influenza A/B strands. The tests come as companies race to find a vaccine to a disease which has killed more than 860,000 people globally since the outbreak emerged late last year in China with more than 26 million cases registered. noo/cdw/wdb
schema:headline	US backs Roche's virus-flu differentiation test
schema:mentions	Roche Diagnostics Emergency Use Authorization Health system Respiratory tract infection Hoffmann-La Roche Flu season Clarence Thomas Switzerland Food and Drug Administration Influenza Chief executive officer Vaccine United States China Severe acute respiratory syndrome coronavirus 2 Certification mark Nasopharyngeal swab dbpedia:B_testing CDW
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-09-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	93 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software